Effective with date of service Oct. 22, 2021, Medicaid and NC Health Choice programs cover afamelanotide implant, for subcutaneous use (Scenesse®).
Topics Related to All Providers
Summary network adequacy results for Standard Plans are available.
This group includes MAFDN Family Planning Medicaid and uninsured MCV beneficiaries.
AMH Provider Manual 2.2 reflects North Carolina’s Integrated Care for Kids (InCK) pilot program expectations and changes that impact Advanced Medical Home Tier 3 contracts with Standard Plans.
Effective Dec. 31, 2021, NC Medicaid will end several of the temporary COVID-19 rate increases. Some of the rate increases in effect in December 2021 will be extended – at either current or revised levels - through Jan. 31, 2022.
In order to ensure optimal access to care for NC Medicaid beneficiaries and to support providers during the recent COVID-19 surge, NC Medicaid is extending the Hospital at Home program through March 31, 2022.
The NC Medicaid Electronic Health Record (EHR) Incentive Program is no longer accepting Program Year 2021 attestations.
The seven-part series covers current policies and procedures under the new NC Medicaid Managed Care guidelines.
Standard Plans temporarily extended minimum appeal timeframes to support the transition to NC Medicaid Managed Care.
The Food and Drug Administration and the Advisory Committee on Immunization Practices have authorized COVID-19 boosters for all adults (18 years and older).